SCHEMBL14985162

SCHEMBL14985162

COC(=O)/C=C/C(=O)N(O)CCCCNCc1ccc(CN)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM6B O15054 3/20 0.77
KDM4A O75164 2/20 0.77
KDM2A Q9Y2K7 1/20 0.77
KDM4E B2RXH2 4/20 0.49
KDM4C Q9H3R0 2/20 0.49
EGLN2 Q96KS0 1/20 0.49
EGLN1 Q9GZT9 1/20 0.49
EGLN3 Q9H6Z9 1/20 0.49
HIF1AN Q9NWT6 1/20 0.49
PHF8 Q9UPP1 1/20 0.49
CHRM2 P08172 2/20 0.38
LOXL2 Q9Y4K0 1/20 0.37
CCR6 P51684 1/20 0.36
PAX8 Q06710 1/20 0.36
TPSAB1 Q15661 4/20 0.35
SLC2A1 P11166 1/20 0.34
HDAC3 O15379 2/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC2 Q92769 2/20 0.34
HDAC8 Q9BY41 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14985134 0.91 KDM6B (0.62) KDM6BKDM4AKDM2AKDM4EKDM4C
SCHEMBL14981984 0.89 KDM6B (0.61) KDM6BKDM4AKDM2AKDM4EKDM4C
SCHEMBL14981985 0.87 KDM6B (1.00) KDM6BKDM4AKDM2AKDM4EKDM4C
SCHEMBL14981960 0.84 KDM4A (0.54) KDM6BKDM4AKDM2AKDM4EKDM4C
SCHEMBL14985030 0.83 KDM6B (0.56) KDM6BKDM4AKDM2AKDM4EKDM4C
SCHEMBL14985132 0.83 KDM6B (0.53) KDM6BKDM4AKDM2AKDM4EKDM4C
SCHEMBL14985133 0.80 KDM6B (0.63) KDM6BKDM4AKDM2AKDM4EKDM4C
SCHEMBL14985029 0.80 KDM4E (0.66) KDM6BKDM4AKDM2AKDM4EKDM4C
SCHEMBL14985161 0.78 KDM6B (0.80) KDM6BKDM4AKDM2AKDM4EKDM4C
SCHEMBL14985090 0.78 KDM6B (0.57) KDM6BKDM4AKDM2AKDM4EKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735622-B2 Histone demethylase inhibitors and methods for using the same THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2014-05-27 US disclosed
US-20130137720-A1 HISTONE DEMETHYLASE INHIBITORS AND METHODS FOR USING THE SAME The Regents of the University of Colorado, a body corporated (US) 2013-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137720-A1 HISTONE DEMETHYLASE INHIBITORS AND METHODS FOR USING THE SAME KDM1A, KDM3A, KDM7A KDM6B 15/4885KDM4A 9/4885KDM2A 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.